Trademark: 77628732
Word
ZONITOR
Status
Dead
Status Code
606
Status Date
Monday, January 31, 2011
Serial Number
77628732
Mark Type
4000
Filing Date
Monday, December 8, 2008
Published for Opposition
Tuesday, April 7, 2009
Abandoned Date
Monday, January 31, 2011

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Trademark Events
Jan 31, 2011
Abandonment Notice Mailed - No Use Statement Filed
Jan 31, 2011
Abandonment - No Use Statement Filed
Jul 8, 2010
Assigned To Examiner
Jun 30, 2010
Notice Of Approval Of Extension Request E-Mailed
Jun 29, 2010
Extension 2 Granted
Jun 2, 2010
Extension 2 Filed
Jun 28, 2010
Case Assigned To Intent To Use Paralegal
Jun 2, 2010
Teas Extension Received
May 14, 2010
Teas Change Of Correspondence Received
May 3, 2010
Teas Change Of Correspondence Received
Feb 25, 2010
Attorney Revoked And/Or Appointed
Feb 25, 2010
Teas Revoke/Appoint Attorney Received
Dec 4, 2009
Extension 1 Granted
Dec 4, 2009
Extension 1 Filed
Dec 4, 2009
Teas Extension Received
Jun 30, 2009
Noa Mailed - Sou Required From Applicant
May 12, 2009
Assigned To Examiner
Apr 7, 2009
Published For Opposition
Mar 18, 2009
Notice Of Publication
Mar 3, 2009
Law Office Publication Review Completed
Mar 3, 2009
Assigned To Lie
Feb 26, 2009
Approved For Pub - Principal Register
Feb 25, 2009
Assigned To Examiner
Dec 11, 2008
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24